Dr. Slatko’s experience includes six years in drug safety regulatory work at the U.S. Food and Drug Administration as a director in the Office of Medication Error Prevention and Risk Management. He also spent over a decade of time as the CMO of a biopharmaceutical consulting firm, ParagonRx, a Syneos Health (formerly InVentiv Health) company. Previously, he held various drug safety, clinical program, new product planning, medical affairs, and executive leadership roles over a 15-year pharmaceutical industry career at Squibb, DuPont Merck, AstraZeneca, and GlaxoSmithKline. Dr. Slatko received a B.A. from Emory University, a M.D. from the University of Miami School of Medicine, and a M.B.A. from West Chester University. He is Board certified in Internal Medicine.